19.23

1.25% -0.2431

ETFMG Treatments Testing and Advancements ETF (GERM)

Overview News Price History Option Chain Discussions Forecast Dividend History

ETFMG Treatments Testing and Advancements ETF stock is currently priced at $19.23, with a 24-hour trading volume of 274. It has seen a -1.25% decreased in the last 24 hours and a +16.27% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $19.43 pivot point. If it approaches the $19.15 support level, significant changes may occur.

Previous Close:

$19.48

Open:

$19.215

24h Volume:

274

Market Cap:

$N/A

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+5.64%

1M Performance:

+16.27%

6M Performance:

+10.51%

1Y Performance:

-6.86%

1D Range:

$19.21

$19.23

52W Range:

$15.67

$21.48

ETFMG Treatments Testing and Advancements ETF Stock (GERM) Company Profile

Name

ETFMG Treatments Testing and Advancements ETF

Sector

Financial (4566)

Industry

Exchange Traded Fund (3096)

Phone

(877) 756-PURE

Address

Employee

Twitter

Next Earnings Date

Latest SEC Filings

GERM's Discussions on Twitter

ETFMG Treatments Testing and Advancements ETF Stock (GERM) Latest News

Amplify ETFs Completes Acquisition to Reach $9.1 Billion AUM Across 31 ETFs - Yahoo Finance

Yahoo Finance

ETFMG Treatments Testing and Advancements ETF Stock (GERM) Financials Data

There is no financial data for ETFMG Treatments Testing and Advancements ETF (GERM). Check out other stocks for more information.

The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.